相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The Opioid Crisis: a Comprehensive Overview
Nalini Vadivelu et al.
CURRENT PAIN AND HEADACHE REPORTS (2018)
Colorectal Transit and Volume During Treatment With Prolonged-release Oxycodone/Naloxone Versus Oxycodone Plus Macrogol 3350
Jakob L. Poulsen et al.
JOURNAL OF NEUROGASTROENTEROLOGY AND MOTILITY (2018)
Opioid drugs and stercoral perforation of the colon: Case report and review of literature
Renee Poitras et al.
INTERNATIONAL JOURNAL OF SURGERY CASE REPORTS (2018)
Pathophysiology, diagnosis, and management of opioid-induced constipation
Adam D. Farmer et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2018)
European Pain Federation position paper on appropriate opioid use in chronic pain management
T. O'Brien et al.
EUROPEAN JOURNAL OF PAIN (2017)
Lubiprostone for Opioid-Induced Constipation Does Not Interfere with Opioid Analgesia in Patients with Chronic Noncancer Pain
Egilius L. H. Spierings et al.
PAIN PRACTICE (2017)
Tapentadol Prolonged Release for Chronic Pain: A Review of Clinical Trials and 5 Years of Routine Clinical Practice Data
Ralf Baron et al.
PAIN PRACTICE (2017)
Prevalence and clinical features of opioid-induced constipation in the general population: A French study of 15,000 individuals
P. Ducrotte et al.
UNITED EUROPEAN GASTROENTEROLOGY JOURNAL (2017)
Randomized Phase III and Extension Studies of Naldemedine in Patients With Opioid-Induced Constipation and Cancer
Nobuyuki Katakami et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Randomized, Double-Blind Trial of Oral Methylnaltrexone for the Treatment of Opioid-Induced Constipation in Patients with Chronic Noncancer Pain
Richard Rauck et al.
PAIN PRACTICE (2017)
Naldemedine versus placebo for opioid-induced constipation (COMPOSE-1 and COMPOSE-2): two multicentre, phase 3, double-blind, randomised, parallel-group trials
Martin Hale et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2017)
Prucalopride: A Review in Chronic Idiopathic Constipation
Karly P. Garnock-Jones
DRUGS (2016)
Opioid-induced bowel dysfunction in healthy volunteers assessed with questionnaires and MRI
Matias Nilsson et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2016)
Alvimopan combined with enhanced recovery strategy for managing postoperative ileus after open abdominal surgery: a systematic review and meta-analysis
Liang-Liang Xu et al.
JOURNAL OF SURGICAL RESEARCH (2016)
The Impact of Opioid Treatment on Regional Gastrointestinal Transit
Jakob L. Poulsen et al.
JOURNAL OF NEUROGASTROENTEROLOGY AND MOTILITY (2016)
Methylnaltrexone for opioid-induced constipation: review and meta-analyses for objective plus subjective efficacy and safety outcomes
Waldemar Siemens et al.
THERAPEUTICS AND CLINICAL RISK MANAGEMENT (2016)
Opioid-induced constipation: advances and clinical guidance
Alfred D. Nelson et al.
THERAPEUTIC ADVANCES IN CHRONIC DISEASE (2016)
Definition, diagnosis and treatment strategies for opioid-induced bowel dysfunction-Recommendations of the Nordic Working Group
Asbjorn M. Drewes et al.
SCANDINAVIAN JOURNAL OF PAIN (2016)
A Randomized, Placebo-Controlled Trial of Lubiprostone for Opioid-Induced Constipation in Chronic Noncancer Pain
M. Mazen Jamal et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2015)
Definitions and Outcome Measures of Clinical Trials Regarding Opioid-induced Constipation A Systematic Review
Jan Gaertner et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2015)
A randomized double-blind, placebo-controlled efficacy and safety study of ALO-02 (extended-release oxycodone surrounding sequestered naltrexone) for moderate-to-severe chronic low back pain treatment
Richard L. Rauck et al.
PAIN (2015)
Consensus Recommendations on Initiating Prescription Therapies for Opioid-Induced Constipation
Charles E. Argoff et al.
PAIN MEDICINE (2015)
Randomised clinical trial: the long-term safety and tolerability of naloxegol in patients with pain and opioid-induced constipation
L. Webster et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2014)
Oxycodone/Naloxone Prolonged-Release: A Review of Its Use in the Management of Chronic Pain While Counteracting Opioid-Induced Constipation
Celeste B. Burness et al.
DRUGS (2014)
Lubiprostone: pharmacokinetic, pharmacodynamic, safety and regulatory aspects in the treatment of constipation-predominant irritable bowel syndrome
Emanuel Raschi et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2014)
Naloxegol for Opioid-Induced Constipation in Patients with Noncancer Pain
William D. Chey et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
A Randomized Study of Lubiprostone for Opioid-Induced Constipation in Patients with Chronic Noncancer Pain
Byron Cryer et al.
PAIN MEDICINE (2014)
Information on risk of constipation for Danish users of opioids, and their laxative use
Anton Pottegard et al.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY (2014)
American Gastroenterological Association Technical Review on Constipation
Adil E. Bharucha et al.
GASTROENTEROLOGY (2013)
Linaclotide Inhibits Colonic Nociceptors and Relieves Abdominal Pain via Guanylate Cyclase-C and Extracellular Cyclic Guanosine 3′,5′-Monophosphate
Joel Castro et al.
GASTROENTEROLOGY (2013)
A phase 2, double-blind, randomized, placebo-controlled, dose-escalation study to evaluate the efficacy, safety, and tolerability of naloxegol in patients with opioid-induced constipation
Lynn Webster et al.
PAIN (2013)
Laxative prescriptions to cancer outpatients receiving opioids: a study from the Norwegian prescription database
Lars Morten Skollerud et al.
SUPPORTIVE CARE IN CANCER (2013)
Linaclotide for Irritable Bowel Syndrome With Constipation: A 26-Week, Randomized, Double-blind, Placebo-Controlled Trial to Evaluate Efficacy and Safety
William D. Chey et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2012)
A 12-Week, Randomized, Controlled Trial With a 4-Week Randomized Withdrawal Period to Evaluate the Efficacy and Safety of Linaclotide in Irritable Bowel Syndrome With Constipation
Satish Rao et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2012)
A Multi-institutional Study Analyzing Effect of Prophylactic Medication for Prevention of Opioid-induced Gastrointestinal Dysfunction
Masashi Ishihara et al.
CLINICAL JOURNAL OF PAIN (2012)
Opioid-Induced Bowel Dysfunction Pathophysiology and Management
Christina Brock et al.
DRUGS (2012)
Quality of life benefits and cost impact of prolonged release oxycodone/naloxone versus prolonged release oxycodone in patients with moderate-to-severe non-malignant pain and opioid-induced constipation: a UK cost-utility analysis
William Dunlop et al.
JOURNAL OF MEDICAL ECONOMICS (2012)
The pharmacokinetics, pharmacodynamics, clinical efficacy, safety and tolerability of linaclotide
Noel Lee et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2011)
The Bowel Function Index for Evaluating Constipation in Pain Patients: Definition of a Reference Range for a Non-constipated Population of Pain Patients
M. A. Ueberall et al.
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2011)
A Randomized, Placebo-Controlled Phase 3 Trial (Study SB-767905/013) of Alvimopan for Opioid-lnduced Bowel Dysfunction in Patients With Non-Cancer Pain
Gordon Irving et al.
JOURNAL OF PAIN (2011)
Subcutaneous Methylnaltrexone for Treatment of Opioid-Induced Constipation in Patients With Chronic, Nonmalignant Pain: A Randomized Controlled Study
Edward Michna et al.
JOURNAL OF PAIN (2011)
Effect of subcutaneous methylnaltrexone on patient-reported constipation symptoms
Shrividya S. Iyer et al.
VALUE IN HEALTH (2011)
Opiate-induced oesophageal dysmotility
R. E. Kraichely et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2010)
Efficacy and Safety of Prucalopride in Patients with Chronic Noncancer Pain Suffering from Opioid-Induced Constipation
Cornelius E. J. Sloots et al.
DIGESTIVE DISEASES AND SCIENCES (2010)
Methylnaltrexone and Gastrointestinal Perforation
Ann Corken Mackey et al.
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT (2010)
Opioid-induced bowel disorders and narcotic bowel syndrome in patients with chronic non-cancer pain
A. K. Tuteja et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2010)
A randomised controlled trial with prolonged-release oral oxycodone and naloxone to prevent and reverse opioid-induced constipation
Winfried Meissner et al.
EUROPEAN JOURNAL OF PAIN (2009)
Combined prolonged-release oxycodone and naloxone improves bowel function in patients receiving opioids for moderate-to-severe non-malignant chronic pain: a randomised controlled trial
O. Loewenstein et al.
EXPERT OPINION ON PHARMACOTHERAPY (2009)
Nausea and Vomiting Side Effects with Opioid Analgesics during Treatment of Chronic Pain: Mechanisms, Implications, and Management Options
Frank Porreca et al.
PAIN MEDICINE (2009)
Opioid receptors in the gastrointestinal tract
Peter Holzer
REGULATORY PEPTIDES (2009)
Methylnaltrexone: a novel approach for the management of opioid-induced constipation in patients with advanced illness
Laura Diego et al.
Expert Review of Gastroenterology & Hepatology (2009)
Validation of the Bowel Function Index to detect clinically meaningful changes in opioid-induced constipation
A. M. Rentz et al.
JOURNAL OF MEDICAL ECONOMICS (2009)
How to do and interpret a rectal examination in gastroenterology
Nicholas J. Talley
AMERICAN JOURNAL OF GASTROENTEROLOGY (2008)
Fixed-ratio combination oxycodone/naloxone compared with oxycodone alone for the relief of opioid-induced constipation in moderate-to-severe noncancer pain
K. Simpson et al.
CURRENT MEDICAL RESEARCH AND OPINION (2008)
Analgesic Efficacy and Safety of Oxycodone in Combination With Naloxone as Prolonged Release Tablets in Patients With Moderate to Severe Chronic Pain
Dana Vondrackova et al.
JOURNAL OF PAIN (2008)
Adverse effects of transdermal opiates treating moderate-severe cancer pain in comparison to long-acting morphine: A meta-analysis and systematic review of the literature
Davide Tassinari et al.
JOURNAL OF PALLIATIVE MEDICINE (2008)
Validation of the PAC-SYM questionnaire for opioid-induced constipation in patients with chronic low back pain
R Slappendel et al.
EUROPEAN JOURNAL OF PAIN (2006)
Development and validation of the Patient Assessment of Constipation Quality of Life questionnaire
P Marquis et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2005)
Prevalence of opioid adverse events in chronic non-malignant pain: systematic review of randomised trials of oral opioids
RA Moore et al.
ARTHRITIS RESEARCH & THERAPY (2005)
Relationship between motor function of the proximal stomach and transient lower oesophageal sphincter relaxation after morphine
R Penagini et al.
GUT (2004)
SPI-0211 activates T84 cell chloride transport and recombinant human ClC-2 chloride currents
J Cuppoletti et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2004)
Function of opioids in the enteric nervous system
JD Wood et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2004)
The opioid system in the gastrointestinal tract
C Sternini et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2004)
Abdominal distension after colonic lactulose fermentation recorded by a new extensometer
G Basilisco et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2003)
Opioid-induced bowel dysfunction - Pathophysiology and potential new therapies
A Kurz et al.
DRUGS (2003)
Low-dose oral naloxone reverses opioid-induced constipation and analgesia
MW Liu et al.
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT (2002)
Linear discriminant analysis of symptoms in patients with chronic constipation - Validation of a new scoring system (KESS)
CH Knowles et al.
DISEASES OF THE COLON & RECTUM (2000)
分享论文
